Study to Check the Efficacy and Safety of Recombinant BCG Vaccine in Prevention of TB Recurrence
Clinical trial NCT03152903 · COMPLETED
Trial details
- NCT number
- NCT03152903
- Sponsor
- Serum Institute of India Pvt. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-15
- Primary completion
- 2023-12-29
- Enrollment
- 2000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.